¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® hypertension ÇÑ±Û °íÇ÷¾Ð
¼³¸í   
  µ¿¸ÆÀÇ Ç÷¾ÐÀÌ ³ôÀº °Í. ÀϹÝÀûÀ¸·Î ¸»Çϴ °íÇ÷¾ÐÀº ÀÌ µ¿¸Æ¼º °íÇ÷¾ÐÀ» ¸»ÇÑ´Ù. Ç÷¾ÐÀ̶õ Ç÷°ü¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϴ °ÍÀ¸·Î ´ë°³ Æ¯ÀÌÇÑ ¼³¸íÀÌ ¾øÀ¸¸é µ¿¸ÆÀÇ ¾Ð·ÂÀ» ¸»ÇÑ´Ù. Ç÷¾Ð¿¡´Â ¼öÃà±âÇ÷¾Ð°ú À̿ϱâÇ÷¾ÐÀÌ ÀÖ´Ù. ¼öÃà±âÇ÷¾ÐÀ̶õ ½ÉÀåÀÌ ¼öÃàÇÒ ¶§ÀÇ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϰí À̿ϱâ Ç÷¾ÐÀ̶õ ½ÉÀåÀÌ ÀÌ¿ÏÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»ÇÑ´Ù. ´ç¿¬È÷ ¼öÃà±â Ç÷¾ÐÀÌ À̿ϱâ Ç÷¾Ðº¸´Ù ³ô´Ù. Ç÷¾ÐÀ» ¸»ÇÒ ¶§¿¡ 120/80À̶ó°í Àû´Â °ÍÀÇ ¾ÕÀÇ °ÍÀº ¼öÃà±â Ç÷¾ÐÀ» ÀǹÌÇÏ°í µÚ¿¡ Àû´Â 80Àº À̿ϱâ Ç÷¾ÐÀ» ÀǹÌÇÑ´Ù.
  
  °íÇ÷¾ÐÀº ÁַΠÀ̿ϱâÀÇ Ç÷¾ÐÀ» ±âÁØÀ¸·Î Á¤ÇÑ´Ù. ¿©·¯ °¡Áö ±âÁØÀÌ ÀÖÀ¸³ª À̿ϱâ Ç÷¾ÐÀÌ 90mmHgÀÌ»óÀΠ°æ¿ì¸¦ ¸»ÇÑ´Ù. °íÇ÷¾Ð ÀÚü¿¡ ÀÇÇÑ Áõ»óÀº º°·Î ¾ø´Ù. ´Ù¸¸ °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´Áõ°ú µ¿¸Æ°æÈ­ÀÇ ÃËÁø¿¡ ÀÇÇØ º´¹ßÇϴ Áúȯ¿¡ ÀÇÇÏ¿© Áõ»óÀÌ »ý±ä´Ù. °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´ÁõÀº ´ë°³ Ç÷°ü¿¡ °É¸®´Â °úµµÇÑ ¾Ð·ÂÀ¸·Î ÀÎÇÑ Ç÷°üÀÇ ¼Õ»óÀÌ Áß¿äÇÑ ¿øÀÎÀÌ´Ù.
  
  °íÇ÷¾ÐÀº µ¿¸Æ°æÈ­ÀÇ ÁÖ¿ä À¯¹ßÀÎÀÚ ÁßÀÇ ÇϳªÀÌ´Ù. µ¿¸Æ°æÈ­´Â µ¿¸ÆÀÇ º®ÀÌ µÎÅÍ¿öÁö°í µ¿¸ÆÀ̠ź·ÂÀ» ÀÒ¾î¹ö¸®´Â ÁúȯÀÌ´Ù. ¾î¶² µ¿¸ÆÀÌ µ¿¸Æ°æÈ­¿¡ °É¸®¸é ÀÌ µ¿¸ÆÀº µÎÅÍ¿öÁø Ç÷°üº®¿¡ ÀÇÇØ¼­ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù. ÀÌ·¸°Ô µÇ¸é ±× µ¿¸ÆÀ¸·ÎºÎÅÍ Ç÷¾×À» °ø±Þ¹Þ´ø Àå±â´Â Ç÷¾×À» Àû°Ô °ø±Þ¹Þ°Ô µÇ°í ±× Á¤µµ°¡ ½ÉÇϰԠµÇ¸é ±× Àå±â´Â °á±¹ ¼Õ»óÀ» ÀÔ°Ô µÈ´Ù. µ¿¸Æ°æÈ­·Î ÀÎÇÑ Áúº´ÀÇ ´ëÇ¥ÀûÀΠ¿¹´Â ½ÉÀåÀÇ ±ÙÀ°¿¡ Ç÷¾×À» °ø±ÞÇϴ ½ÉÀ嵿¸Æ¿¡ µ¿¸Æ°æÈ­ÀÇ º¯È­°¡ ¿À´Â ½ÉÀ嵿¸Æº´ÀÌ´Ù.
  
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ ¾²À̴ ¾à¹°Àº ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù.
  
  -ÀÌ´¢Á¦-ÄáÆÏ¿¡¼­ ¼öºÐ°ú ÀüÇØÁúÀÇ ¹èÃâÀ» ÃËÁø½Ã۴ ¾à¹°. Ã¼³»ÀÇ ¼öºÐÀÇ ¾çÀ» °¨¼Ò½ÃÄѼ­ Ç÷¾×ÀÇ È帣´Â ¾çÀ» Àû°ÔÇÏ°í ¶Ç Ç÷°üÁÖÀ§ Á¶Á÷ÀÇ ¼öºÐÀÇ °¨¼Ò·Î Ç÷°üÀ» È®Àå½Ã۴ ¿ªÇÒ(Ç÷°üÀÌ ÀÖ°í ±× Ç÷°üÀ» ½×°í Àִ Á¶Á÷¿¡ ¼öºÐÀÌ Â÷ ÀÖÀ¸¸é ±× Á¶Á÷ÀÌ Ç÷°üÀ» ´­·¯¼­ Ç÷°üÀÌ È®ÀåÇϴ °ÍÀ» ¹æÇØÇÑ´Ù)·Î Ç÷¾ÐÀ» °¨¼Ò½ÃŲ´Ù.
  
  -Ä®½·-Åë·ÎÂ÷´ÜÁ¦£­¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Áï Ç÷°üÀÇ ¼öÃà¿¡ °ü¿©Çϴ Ç÷°üµµ ¿ª½Ã ¼öÃàÀ» À§Çؼ­´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Ä®½·-Åë·ÎÂ÷´ÜÁ¦´Â ±ÙÀ°¼¼Æ÷ ¼ÓÀ¸·Î Ä®½·ÀÌ µé¾î°¡´Â °ÍÀ» ¹æÁöÇØ¼­ Ç÷°ü±ÙÀ°ÀÇ ¼öÃàÀ» ¹æÇØÇϰí À̷ΠÀÎÇØ¼­ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÑ´Ù.
  
  -¾ËÆÄÂ÷´ÜÁ¦, º£Å¸Â÷´ÜÁ¦-Ç÷°üÀº ÀÚÀ²½Å°æ°èÀÇ Áö¹è¸¦ ¹Þ´Â´Ù. ±×Áß¿¡¼­µµ Ç÷°üÀº ±³°¨½Å°æÀÇ ¿µÇâ¿¡ ÀÇÇØ¼­ ¼öÃà°ú ÀÌ¿ÏÀ» ÇÑ´Ù. ±³°¨½Å°æÀÇ ÀÛ¿ëÀº ±× ¼ö¿ëü¿¡ µû¶ó ´Þ¶óÁø´Ù. ±³°¨½Å°æÀÇ ¼ö¿ëüÀÇ Á¾·ù¿¡´Â ¾ËÆÄ¼ö¿ëü¿Í º£Å¸¼ö¿ëü°¡ ÀÖ´Ù. Ç÷°üÀ» Áö¹èÇϰí Àִ ±³°¨½Å°æ¿¡¼­ ¾ËÆÄ¼ö¿ëü´Â Ç÷°üÀÇ ¼öÃàÀ» ÀÏÀ¸Å°°í º£Å¸¼ö¿ëü´Â Ç÷°üÀÇ È®ÀåÀ» ÀÏÀ¸Å²´Ù. ±×·¯¹Ç·Î ¾ËÆÄ¼ö¿ëüÀÇ ÀÛ¿ëÀ» ¸·´Â °æ¿ì¿¡ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÒ ¼ö ÀÖ°í º£Å¸-¼ö¿ëüÀÇ ÀÛ¿ëÀ» Ç×Áø½Ãų °æ¿ì¿¡ ¿ª½Ã Ç÷°üÀÇ È®Á¤À» À¯µµÇÒ ¼ö ÀÖ´Ù.
¿µ¹® renal hypertension ÇÑ±Û ÄáÆÏ¼º°íÇ÷¾Ð
¼³¸í   
  ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì Ã¼³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇϰԠµÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇϰԠµÈ´Ù. Ä¡·á´Â ¿øÀΠÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀΠÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary hypertension
    ¿ø¹ß¼º°íÇ÷¾Ð
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
  • adrenal hypertension
    ºÎ½Å¼º°íÇ÷¾Ð
  • borderline hypertension
    °æ°è°íÇ÷¾Ð
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • hypertension
    1. °íÇ÷¾Ð 2. °íÇ÷¾ÐÁõ 3. °í¾Ð
  • intracranial hypertension
    µÎ°³³»¾Ð»ó½Â
  • juvenile hypertension
    ¼Ò¾Æ°íÇ÷¾Ð
  • labile hypertension
    ºÒ¾ÈÁ¤°íÇ÷¾Ð
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • ocular hypertension
    °í¾È¾Ð
  • ocular hypertension indicator
    °í¾È¾ÐÁöÇ¥
  • orthostatic hypertension
    ±â¸³°íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypertension
    °íÇ÷¾Ð
  • ocular hypertension
    °í¾È¾ÐÁõ
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
  • primary aldosteronism
    ÀÏÂ÷¾Ëµµ½ºÅ×·ÐÁõ
  • primary cancer
    ¿ø¹ß¾Ï
  • primary constriction
    (¢¡centromere) ¸Åµì, µ¿¿øÃ¼, Áß½ÉÀý
  • primary health care
    ÀÏÂ÷º¸°ÇÀÇ·á
  • primary cholestatic liver disease
    ÀÏÂ÷¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ÀÏÂ÷´ãÁóÁ¤Ã¼°£Áúȯ
  • primary irritant dermatitis
    ¿ø¹ßÀÚ±ØÇǺο°
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary
    ¿ø¹ß-, ÀÏÂ÷-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary hypertension
    (¢¡essential hypertension) º»Å°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
  • adrenal hypertension
    ºÎ½Å°íÇ÷¾Ð
  • borderline hypertension
    °æ°è°íÇ÷¾Ð
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • hypertension
    °íÇ÷¾Ð
  • intracranial hypertension
    µÎ°³³»¾Ð»ó½Â
  • juvenile hypertension
    ¼Ò¾Æ°íÇ÷¾Ð
  • labile hypertension
    (¢¡borderline hypertension) °æ°è°íÇ÷¾Ð
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • ocular hypertension
    °í¾È¾ÐÁõ
  • orthostatic hypertension
    ±â¸³°íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary hypertension
    ¿ø¹ß(¼º) °íÇ÷¾ÐÁõ (¡­ÍÔúìäâñø).
  • primary hypertension
    ¿ø¹ß(¼º) °íÇ÷¾ÐÁõ(ê«Û¡(àõ) ÍÔúìäâñø)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(¡­øËÍÔúìäâñø).
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(ê«Û¡(àõ) øËÍÔúìäâñø)
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • Goldblatt hypertension
    Goldblatt °íÇ÷¾Ð(ÍÔúìäâ)
  • Hypertension
    °íÇ÷¾Ð(ÍÔúìäâ)
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâñø), ±äÀåÇ×Áø(Áõ)(ÑÌíåùñòäñø).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâ)
  • hypertension cranienne ºÒ
    ³ú¾ÐÇ×Áø(Áõ).
  • hypertension paroxystique ºÒ
    ¹ßÀÛ¼º °íÇ÷¾Ð(Áõ)(Û¡íÂàõÍÔúìäâñø).
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • hypertension,essential
    º»Å¼º(Üâ÷¾àõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary hypertension
    ¿ø¹ß(¼º) °íÇ÷¾ÐÁõ (¡­ÍÔúìäâñø).
  • primary hypertension
    ¿ø¹ß(¼º) °íÇ÷¾ÐÁõ(ê«Û¡(àõ) ÍÔúìäâñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(¡­øËÍÔúìäâñø).
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(ê«Û¡(àõ) øËÍÔúìäâñø)
  • primary yolk sac [primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac [primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
  • primary yolk sac[primary vitelline sac]
  • primary yolk sac[primary vitelline sac]
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • borderline hypertension
    °æ°è¿ª°íÇ÷¾Ð.
  • borderline hypertension
    °æ°è¿ª °íÇ÷¾Ð(ÌÑÍ£æ´ ÍÔúìäâ).
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð.
  • essential hypertension
    º»Å¼º(Üâ÷¾àõ)°íÇ÷¾Ð(ÍÔúìäâ)
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâñø), ±äÀåÇ×Áø(Áõ)(ÑÌíåùñòäñø).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Primary yolk sac [Primary vitellin sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Primary yolk sac [Primary vitelline sac]
    ÀÏÂ÷³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷³­È²³¶
  • Diploid primary gametocyte
    µÎ¹è¼öüÀÏÂ÷»ý½Ä¼¼Æ÷
    [¿¾ ¿ë¾î] ¹è¼öüÁ¦ÀÏ»ý½Ä¼¼Æ÷
  • Reticulofibrous membranous bone [Primary membranous bone]
    ¼¼¸Á¼¶À¯¸·»À [ÀÏÂ÷¸·»À]
    [¿¾ ¿ë¾î] ÀÏÂ÷¸·¼º°ñ
  • Premaxilla (Primary palate)
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ¾ÇÀü±¸°³
  • Premaxilla [Primary palate]
    ¾ÕÀ§ÅλÀ [ÀÏÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] Àü»ó¾Ç°ñ
  • Primary vitelline sac
    ¿ø½Ã³­È²ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ¿ø½Ã³­È²³¶
  • Primary amnion
    ¿ø½Ã¾ç¸·
    [¿¾ ¿ë¾î] ¿ø½Ã¾ç¸·
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary medullary cavity
    ÀÏÂ÷°ñ¼ö°ø°£[ÀÏÂ÷»À¼ÓÁú°ø°£]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ö°­
  • Primary polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • Primary bronchus
    ÀÏÂ÷±â°üÁö
    [¿¾ ¿ë¾î] ¿ø½Ã±â°üÁö
  • Primary oocyte
    ÀÏÂ÷³­¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­¸ð¼¼Æ÷
  • Primary follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary amebic meningoencephalitis
    ¿ø¹ß¼º¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary infection
    ÀÏÂ÷°¨¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
  • primary acidosis
    ¿ø¹ß¼º »êÁõ(ê«Û¡àõß«ñø)
  • primary active transport
    ÀÏÂ÷ ´Éµ¿¼ö¼Û(ìéó­ÒöÔÑâÃáê)
  • primary alkali deficit
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°áÇÌ(ÌÀù¹)
  • primary alkali excess
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°úÀ×(Φí¥)
  • primary alkalosis
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®Áõ(ñø)
  • primary amino acid
    ÀÏÂ÷(ìéó­) ¾Æ¹Ì³ë»ê(ß«)
  • primary bile acid
    ÀÏÂ÷ ´ãÁó»ê(ìéó­ÓÅñðß«)
  • primary carbon dioxide deficit
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò °áÇÌ(ê«Û¡àõì£ß«ûù÷©áÈÌÀù¹)
  • primary carbon dioxide excess
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò(ê´Û¡àõ ì£ß«ûù÷©áÈ) °úÀ×(Φí¥)
  • primary charge effect
    ÀÏÂ÷ ÀüÇÏÈ¿°ú(ìéó­ï³ùÃüùÍý)
  • primary culture
    ÀÏÂ÷ ¹è¾ç(ìéó­ÛÆå×)
  • primary deficiency
    ¿ø¹ß¼º °áÇÌ(ê«Û¡àõÌÀù¹)
  • primary derived protein
    ÀÏÂ÷ À¯µµ ´Ü¹éÁú(ìéó­ë¯ÓôÓ±ÛÜòõ)
  • primary filament
    ÀÏÂ÷(ìéó­) Çʶó¸àÆ®
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary hypertension
    ¿ø¹ß(¼º)°íÇ÷¾ÐÁõ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential hypertension
    º»Å¼º°íÇ÷¾Ð
  • hypertension
    °íÇ÷¾ÐÁõ, ±äÀåÇ×ÁøÁõ
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ, ¹®¸Æ°íÇ÷¾Ð
  • renal hypertension
    ½Å¼º°íÇ÷¾Ð
  • renovascular hypertension
    ½ÅÇ÷°ü¼º°íÇ÷¾Ð
  • splenoportal hypertension
    ºñ¹®¸Æ¼º°íÇ÷¾ÐÁõ
  • primary
    ÀÏÂ÷(¼º)ÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ß(¼º)ÀÇ
  • primary amenorrhea
    ¿ø¹ß(¼º)¹«¿ù°æ
  • primary cancer
    ¿ø¹ß¾Ï
  • primary complex
    Ãʱ⺯ȭ±º
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary infiltration
    ÃʱâħÀ±
  • primary lesion
    ÀÏÂ÷¼ºº´º¯, Ãʰ¨¿°¼Ò
  • primary lobule
    ÀÏÂ÷¼Ò¿±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
PHT phenytoin; portal hypertension; primary hyperthyroidism; pulmonary hypertension
PPH past pertinent history; persistent pulmonary hypertension; phosphopyruvate hydratase; postpartum hem...
PH parathyroid hormone; partial hepatectomy; partial hysterectomy; passive hemagglutination; past histo...
DEF decayed primary teeth requiring filling, decayed primary teeth requiring extraction, and primary tee...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STOP Hypertension Swedish Trial in Old Patients with Hypertension
PPH Primary Pulmonary Hypertension
primary SS Primary Sjogren's syndrome
ARH Adrenal regeneration hypertension
AH Arterial Hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary hypertension
    ¿ø¹ß °íÇ÷¾ÐÁõ, ¿ø¹ß¼º °íÇ÷¾ÐÁõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary vaccination :

    primary's area

    Á¦1¿µ¿ª
    ¿îµ¿°ú °¨°¢ºÎ¸¦ Æ÷ÇÔÇÏ´Â ´ë³ú ÇÇÁú ¿µ¿ª.
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð
    1. Ưº°ÇÑ ¿øÀÎÀÌ ¾Ë·ÁÁöÁö ¾ÊÀº °íÇ÷¾ÐÀ» ÀǹÌÇϸç ÀÌ´Â Àüü °íÇ÷¾Ð ȯÀÚÀÇ 85-90£¥¸¦ Â÷ÁöÇÑ´Ù. 2. À¯Àü, Á¤½ÅÀû ½ºÆ®·¹½º, ¿°ºÐÀÇ Áõ°¡ µî Ç÷¾Ð »ó½ÂÀÌ º¹ÇÕÀûÀÎ ¿øÀÎ ÇüÅ·Π³ªÅ¸³­´Ù.
  • hypertension paroxystique
    ºÒ ¹ßÀÛ¼º °íÇ÷¾Ð
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾ÐÁõ, ¿¬¼Ò¼º °íÇ÷¾Ð
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð
  • nephrogenous hypertension
    ½Å¼º °íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸ °íÇ÷¾Ð ÁöÇ¥
  • orthostatic hypertension
    ±â¸³¼º °íÇ÷¾Ð, ÀÚ¼¼¼º °íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ¼º °íÇ÷¾Ð, °£¹®¸Æ °íÇ÷¾Ð, ¹®¸Æ¾Ð Ç×ÁøÁõ, ¹®¸Æ °íÇ÷¾Ð
  • pulmonary arterial hypertension
    Æó ¼øÈ¯ ½Â¾Ð
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð
  • splenoportal hypertension
    ºñ ¹®¸Æ¼º °íÇ÷¾ÐÁõ
  • A alpha primary afferent
    A ¾ËÆÄ ÀÏÂ÷ ±¸½É ½Å°æ
    ±Ù¹æÃß ³»ÀÇ ±Ù ¼¶À¯¿¡ Á¸ÀçÇÏ´Â °¨°¢½Å°æÀÇ Çϳª·Î ¥°a °¨°¢ ½Å°æÀ̶ó°íµµ ÇÑ´Ù. Á÷°æÀº 22§­, Àüµµ ¼Óµµ´Â 120§½ÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
primary hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
primary pulmonary hypertension A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs. The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
accelerated hypertension <cardiology> A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
adrenal hypertension Hypertension due to an adrenal medullary pheochromocytoma or to hyperactivity or functioning tumour of the adrenal cortex.
(05 Mar 2000)
benign hypertension Hypertension that runs a relatively long and symptomless course.
(05 Mar 2000)
borderline hypertension By consensus, that blood pressure zone between highest acceptable "normal" blood pressure and hypertensive blood pressure. The Framingham Heart Study defines this as pressures between 140 and 160 mm Hg systolic and 90 and 95 mm Hg diastolic.
(05 Mar 2000)
pale hypertension Hypertension with pallor of the skin, a severe form with pronounced constriction of peripheral vessels.
(05 Mar 2000)
malignant hypertension A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
renal hypertension Hypertension secondary to renal disease.
(05 Mar 2000)
renovascular hypertension Hypertension produced by renal arterial obstruction.
(05 Mar 2000)
Goldblatt hypertension Increased blood pressure following obstruction of blood flow to one kidney.
Synonym: Goldblatt phenomenon.
(05 Mar 2000)
portal hypertension Any increase in the portal vein (in the liver) pressure due to anatomic or functional obstruction (for example alcoholic cirrhosis) to blood flow in the portal venous system. Indicators of portal hypertension are: oesophageal varices, haemorrhoids, enlarged veins on the anterior abdominal wall (caput Medusae) and ascites (fluid within the abdominal cavity).
(27 Sep 1997)
portal hypertension: classification <radiology> Presinusoidal, extrahepatic: portal vein obstruction (extrinsic compression, phlebitis, OC, coagulopathy, tumour invasion, pancreatitis, neonatal omphalitis), dynamic: traumatic/neoplastic arterioportal fistula, segmental portal hypertension: splenic/superior mesenteric vein occlusion, intrahepatic (obstruction of portal venules): congenital hepatic fibrosis, primary biliary cirrhosis, sarcoid, myelofibrosis, schistosomiasis, idiopathic noncirrhotic fibrosis, Wilson disease, reticuloendotheliosis, Felty syndrome, chronic malaria, toxic fibrosis (arsenic, copper, PVC vapors) sinusoidal, cirrhosis, sclerosing cholangitis postsinusoidal, Budd-Chiari syndrome, constrictive pericarditis, congestive heart failure
(12 Dec 1998)
postcapillary pulmonary hypertension <radiology> Heart: LV failure, mitral stenosis, LA myxoma / thrombus, cor triatriatum, Pulmonary veins: congenital stenosis of pulmonary vein origin, mediastinal granulomata and neoplasms, idiopathic pulmonary veno-occlusive disease, anomalous pulmonary venous return
(12 Dec 1998)
postpartum hypertension <obstetrics> Increased blood pressure immediately following the completion of labour.
(05 Mar 2000)
precapillary pulmonary hypertension <radiology> Vascular: increased flow (left to right shunts), decreased flow (tetralogy of Fallot), primary pulmonary hypertension, thromboembolic disease, pulmonary arteritides, Pleuropulmonary: emphysema, diffuse lung disease, fibrothorax, chest deformity, hypoventilation, high-altitude pulmonary hypertension
(12 Dec 1998)
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypertension
    °íÇ÷¾Ð; °úµµ ±äÀå
  • hypertension
    °íÇ÷¾Ð
  • primary
    Áß¿äÇÑ
  • closed primary
    Á¦ÇÑ ¿¹ºñ ¼±°Å(´ç¿ø À¯ÀÚ°ÝÀÚ¸¸ÀÌ ÅõÇ¥ÇÏ´Â Èĺ¸ÀÚ ¼±°Å)
  • dircct primary
    Á÷Á¢ ¿¹¼±
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
  • open primary
    °ø°³ ¿¹¼± ´ëȸ
  • presidential primary
    (°¢ Á¤´çÀÇ)´ëÅë·É ¼±°ÅÀÎ ¿¹¼±È¸
  • primary
    ÃÖÃÊÀÇ;¿ø½ÃÀûÀÎ;¼öÀ§ÀÇ;ÁÖ¿äÇÑ;º»·¡ÀÇ;±Ùº»ÀÇ;Ãʺ¸ÀÇ;Á¦ 1±âÀÇ;1Â÷ÀÇ-Á¦ 1À§ÀÇ »ç¹°;¿ø»ö;ÀÏÂ÷¾î(¸í»ç »ó´ç ¾î±¸);´ëÅë·É Èĺ¸ ¿¹ºñ ¼±°Å
  • primary accent
    Á¦ ÀÏÀÇ ¾Ç¼¾Æ®
  • primary assembly
    ¿¹¼± ´ëȸ;»çÀü ÇùÀÇȸ
  • primary atypical pneumonia
    1Â÷¼º ºñÁ¤Çü Æó·Å
  • primary care
    ÀÏÂ÷ ÀÇ·á(ÀÀ±Þ Ä¡·á µî ÁÖ°ÅÁö¿¡¼­ ÇàÇÏ´Â Ãʱâ ÀÇ·á)
  • primary cell
    1Â÷ ÀüÁö
  • primary coil
    1Â÷ ÄÚÀÏ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á